2256.HK · ABBISKO-B
Hong Kong · RS rating 6 · As of 2026-10-14
| Price | 7.44 HKD |
|---|---|
| 1-day change | -3.6% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 15 / 8 / 13 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 17 / 17 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.1% |
| Market cap (USD) | $720.5M |